AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E113-E121, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toth, M. J.
Right arrow Articles by Poehlman, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toth, M. J.
Right arrow Articles by Poehlman, E. T.
Vol. 281, Issue 1, E113-E121, July 2001

Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women

Michael J. Toth, Cynthia K. Sites, William T. Cefalu, Dwight E. Matthews, and Eric T. Poehlman

Department of Medicine, and Department of Obstetrics and Gynecology, University of Vermont, Burlington, Vermont 05405

Controversy exists regarding the relative importance of adiposity, physical fitness, and physical activity in the regulation of insulin-stimulated glucose disposal. To address this issue, we measured insulin-stimulated glucose disposal [mg · kg fat-free mass (FFM)-1 · min-1; oxidative and nonoxidative components] in 45 nondiabetic, nonobese, premenopausal women (mean ± SD; 47 ± 3 yr) by use of hyperinsulinemic euglycemic clamp (40 mU · m-2 · min-1) and [6,6-2H2]glucose dilution techniques. We also measured body composition, abdominal fat distribution, thigh muscle fat content, maximal oxygen consumption (VO2 max), and physical activity energy expenditure (2H218O kinetics) as possible correlates of glucose disposal. VO2 max was the strongest correlate of glucose disposal (r = 0.63, P < 0.01), whereas whole body and abdominal adiposity showed modest associations (range of r values from -0.32 to -0.46, P < 0.05 to P < 0.01). A similar pattern of correlations was observed for nonoxidative glucose disposal. None of the variables measured correlated with oxidative glucose disposal. The relationship of VO2 max to glucose disposal persisted after statistical control for FFM, percent body fat, and intra-abdominal fat (r = 0.40, P < 0.01). In contrast, correlations of total and regional adiposity measures to insulin sensitivity were no longer significant after statistical adjustment for VO2 max. VO2 max was the only variable to enter stepwise regression models as a significant predictor of total and nonoxidative glucose disposal. Our results highlight the importance of VO2 max as a determinant of glucose disposal and suggest that it may be a stronger determinant of variation in glucose disposal than total and regional adiposity in nonobese, nondiabetic, premenopausal women.

aerobic fitness; body composition; body fat distribution; euglycemic clamp


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, B. C. Cooper, R. E. Pratley, A. Mari, D. E. Matthews, and P. R. Casson
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1035 - E1045.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. E. Yeo, N. P. Hays, R. A. Dennis, P. M. Kortebein, D. H. Sullivan, W. J. Evans, and R. H. Coker
Fat Distribution and Glucose Metabolism in Older, Obese Men and Women
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1393 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, C. K. Sites, D. E. Matthews, and P. R. Casson
Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E483 - E490.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Martin, Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes
Diabetes Care, August 1, 2006; 29(8): 1826 - 1832.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T.-B. Nguyen-Duy, M. Z. Nichaman, T. S. Church, S. N. Blair, and R. Ross
Visceral fat and liver fat are independent predictors of metabolic risk factors in men
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1065 - E1071.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Ross, J. Aru, J. Freeman, R. Hudson, and I. Janssen
Abdominal adiposity and insulin resistance in obese men
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E657 - E663.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online